Icosavax, Inc. (ICVX) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 5 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for ICVX is $27.00, representing a +76.4% upside from the current price of $15.31. Price targets range from a low of $27.00 to a high of $27.00.
